telbivudine and Complications, Infectious Pregnancy
telbivudine has been researched along with Complications, Infectious Pregnancy in 54 studies
Research
Studies (54)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (1.85) | 29.6817 |
2010's | 41 (75.93) | 24.3611 |
2020's | 12 (22.22) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, L; Chen, X; Dai, E; Li, C; Li, S; Lv, X; Zhao, Z; Zhu, B | 1 |
Ran, R; Wang, M; Zhang, H; Zhu, Y | 1 |
Cai, H; Gao, X; Li, Z; Xie, B; Yi, N; Yi, W | 1 |
Chen, C; Han, G; Jiang, H; Ye, X; Zhou, G | 1 |
Ma, LX; Tao, LL; Xu, J | 1 |
Chen, K; Deng, H; Gao, H; Jiao, Q; Lei, Y; Li, H; Liang, S; Lin, L; Liu, H; Shi, Y; Xu, M; Zhuo, L | 1 |
Pan, CQ; Wen, WH; Wong, GL | 1 |
Cao, WH; Hu, YH; Li, MH; Pan, CQ; Wan, G; Wang, Y; Xie, Y; Yi, W; Zeng, HH; Zhang, Y; Zhou, MF | 1 |
Cai, H; Duan, X; Fu, D; Gao, X; Hu, Y; Kang, K; Li, Z; Liu, M; Yi, W; Zhou, M | 1 |
Dong, Z; Hao, A; Li, F; Ma, L; Ma, W; Ren, C; Sun, W; Wang, L; Zhou, L | 1 |
Cao, W; Cao, X; Li, M; Sun, F; Wan, G; Wang, Y; Xie, Y; Yi, W; Zeng, Z; Zhang, Y | 1 |
Li, EM; Li, JQ; Lin, CS; Mei, YY; Mo, ZS; Xiao, LX; Xu, Z | 1 |
Chen, X; Hu, Z; Lu, J; Ma, L; Wang, X; Zheng, S; Zhu, Y | 1 |
Hao, A; Li, F; Ma, L; Song, M; Sun, W; Zhao, B; Zhao, S; Zhou, L | 1 |
Chamroonkul, N; Piratvisuth, T | 1 |
Bai, L; Liu, K; Shang, J; Tang, H; Wang, CC; Wen, Q | 1 |
Chen, T; Liu, J; Zhao, Y | 1 |
Bai, Y; Cai, H; He, T; Jia, J; Liu, M; Ou, X; Yi, W | 1 |
Ding, Y; Dou, XG; Sheng, QJ; Wang, SJ; Wu, YY | 1 |
Li, H; Zeng, J; Zheng, C | 1 |
Jia, J; You, H | 1 |
Cai, H; Liu, M; Yi, W | 1 |
Sarkar, M; Terrault, NA | 1 |
Ji, Y; Jiang, Q; Ju, LL; Tang, X; Wu, KH; Yang, YF; Yu, MM | 1 |
Gerlich, WH | 1 |
Liu, X; Pan, CQ; Pang, Q; Tian, R; Yan, M; Zhang, H | 1 |
Berkley, EM; Dunkelberg, JC; Leslie, KK; Thiel, KW | 1 |
Lu, C; Pan, H; Zheng, J; Zhou, Y | 1 |
Deng, G; He, D; He, Y; Huang, H; Li, J; Li, L; Pan, M; Sun, X; Tan, S; Wang, Y; Wu, Q; Yan, Z; Zeng, Y | 1 |
Cai, H; Shen, Y; Wang, Y; Zeng, H | 1 |
Cai, HD; Cao, YJ; Hu, YH; Liu, M; Yi, W | 1 |
Chen, C; Chen, F; Cheng, Q; Dai, Y; Gong, F; Lin, X; Tu, X | 1 |
Hao, A; Li, M; Liu, W; Ma, L; Song, M; Sun, W; Xin, Y | 1 |
El Agheb, MO; Grange, JD | 1 |
Ditah, I; Ewelukwa, O; Foma, M; Gupta, N; Lim, JK; Njei, B | 1 |
Deng, Y; Hu, P; Kang, J; Wu, W; Yang, Y; Zeng, W; Zhang, D | 1 |
Cao, ZH; Chen, XY; He, ZM; Jin, Y; Liu, YL; Lu, JF; Ma, LN; Zhang, SB | 1 |
Cao, F; Chen, T; Feng, W; Guo, D; Jin, D; Jin, L; Liu, J; Qi, C; Tian, Z; Wang, J; Yan, T; Yuan, N; Zhang, S; Zhao, Y | 1 |
Bai, H; Ding, Y; Dou, XG; Fan, YX; Han, C; Li, BJ; Li, YW; Sheng, QJ; Zhang, C | 1 |
Hou, H; Tan, Z; Wu, L; Xu, C; Yin, Y; Zhou, J | 1 |
Ding, Y; Han, GR; Jiang, HX; Wang, CM; Wang, GJ; Yue, X; Zhao, W; Zhou, L | 1 |
Wang, L; Zhang, LJ | 1 |
But, DY; Fung, J; Lai, CL; Yuen, MF | 1 |
Bai, SF; Cao, MK; Fang, ZX; Han, GR; Jiang, HX; Tang, X; Wang, CM; Wang, GJ; Yue, X; Zhao, W | 1 |
Petersen, J | 1 |
Giles, M; Sasadeusz, J; Visvanathan, K | 1 |
Cao, MK; Han, GR; Jiang, HX; Pan, CQ; Wang, CM; Wang, GJ; Yue, X; Zhao, W | 1 |
Han, GR; Jiang, HX; Kan, NY; Wang, CM; Wang, GJ; Wu, MM; Yue, X | 1 |
Dusheiko, G | 1 |
Jiang, S; Pan, HJ; Zheng, JL; Zhou, YJ | 1 |
Chen, HZ; Deng, M; Gao, S; Ruan, B; Wang, B; Yang, SG; Zhou, X | 1 |
Baak, BC; Bakker, CM; Beuers, UH; Brouwer, JT; Buster, EH; Drenth, JP; Honkoop, P; Janssen, HL; Kerbert-Dreteler, MJ; Koek, GH; Tan, AC; van der Spek, BW; van Erpecum, KJ; van Hoek, B; van Nieuwkerk, KM; van Soest, H; Vrolijk, JM | 1 |
Chen, Y; Liu, XX; Wang, LJ; Wu, YP; Xu, HX; Xu, YF; Yu, YX | 1 |
Chen, R; Liu, SR; Tao, CJ; Zhang, SY | 1 |
Reviews
10 review(s) available for telbivudine and Complications, Infectious Pregnancy
Article | Year |
---|---|
Hepatitis B-management of acute infection and active inflammation in pregnancy-a hepatologist's perspective.
Topics: Adult; Antiviral Agents; Child; DNA, Viral; Female; Gastroenterologists; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Inflammation; Male; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Tenofovir | 2020 |
Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.
Topics: Antiviral Agents; Endemic Diseases; Female; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunization; Immunoglobulins; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Tenofovir; Thymidine; Viral Load | 2017 |
Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairment.
Topics: Animals; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Pregnancy; Pregnancy Complications, Infectious; Renal Insufficiency; Risk; Telbivudine; Thymidine; Treatment Outcome; Viral Load | 2017 |
Telbivudine treatment in chronic hepatitis B: experience from China.
Topics: Antiviral Agents; China; Clinical Trials as Topic; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Treatment Outcome | 2013 |
Hepatitis B and C in pregnancy: a review and recommendations for care.
Topics: Antiviral Agents; Breast Feeding; Cesarean Section; Contraindications; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Telbivudine; Thymidine; Viremia | 2014 |
Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis.
Topics: Antiviral Agents; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Network Meta-Analysis; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Telbivudine; Thymidine; Viral Load | 2016 |
Safety evaluation of telbivudine.
Topics: Adult; Antiviral Agents; Biomarkers; Creatine Kinase; Double-Blind Method; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Isoenzymes; Male; Multicenter Studies as Topic; Muscular Diseases; Nucleosides; Peripheral Nervous System Diseases; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Randomized Controlled Trials as Topic; Telbivudine; Thymidine | 2010 |
Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
Topics: Adenine; Antiviral Agents; Breast Feeding; Female; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2011 |
The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis.
Topics: Antiviral Agents; Female; Hepatitis B Antibodies; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Treatment Outcome | 2012 |
[Efficacy and safety of telbivudine treatment to block mother-to-child transmission of hepatitis B virus: a meta-analysis].
Topics: Antiviral Agents; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Telbivudine; Thymidine | 2012 |
Trials
11 trial(s) available for telbivudine and Complications, Infectious Pregnancy
Article | Year |
---|---|
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission.
Topics: Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Pregnancy Trimester, Second; Telbivudine; Thymidine; Viral Load; Young Adult | 2017 |
Safety of telbivudine treatment for chronic hepatitis B for the entire pregnancy.
Topics: Adult; Antiviral Agents; China; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Treatment Outcome | 2013 |
Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Treatment Outcome; Young Adult | 2014 |
[Long-term efficacy and safety of telbivudine in the treatment of childbearing patients with chronic hepatitis B].
Topics: Adolescent; Adult; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Young Adult | 2014 |
Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Topics: Adolescent; Adult; Antiviral Agents; China; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Longitudinal Studies; Male; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Telbivudine; Thymidine; Treatment Outcome; Viral Load; Young Adult | 2015 |
[Blocking intrauterine infection by telbivudine in pregnant chronic hepatitis B patients].
Topics: Administration, Oral; Antiviral Agents; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Nucleosides; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Thymidine; Treatment Outcome | 2009 |
A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nucleosides; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimidinones; Telbivudine; Thymidine; Treatment Outcome; Young Adult | 2011 |
Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B.
Topics: Adult; Antiviral Agents; Case-Control Studies; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Nucleosides; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Pyrimidinones; Telbivudine; Thymidine | 2012 |
[Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus].
Topics: Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Nucleosides; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Pyrimidinones; Telbivudine; Thymidine; Viral Load; Young Adult | 2012 |
[Efficacy and safety of telbivudine in pregnant chronic hepatitis B patients].
Topics: Adult; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Nucleosides; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Thymidine; Treatment Outcome; Young Adult | 2011 |
[Efficacy of telbivudine in blocking the vertical transmission and the safety observation of discontinuing treatment time after delivery on mother infected with HBV].
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Young Adult | 2012 |
Other Studies
33 other study(ies) available for telbivudine and Complications, Infectious Pregnancy
Article | Year |
---|---|
Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Viral Load | 2021 |
Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load.
Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Telbivudine; Tenofovir; Viral Load | 2023 |
Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.
Topics: Antiviral Agents; Cohort Studies; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Viral Load | 2022 |
Efficacy and Long-term Safety of Telbivudine Usage During Second or Third Trimester in Hepatitis B Surface Antigen Positive Mothers With High Viral Load: A 10-year Prospective Study.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prospective Studies; Telbivudine; Thymidine; Viral Load | 2023 |
Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Infant; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Prospective Studies; Telbivudine; Viral Load; Young Adult | 2019 |
Clinical efficacy and safety in telbivudine- or tenofovir-treated hepatitis B e antigen-positive pregnant women.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Infectious Disease Transmission, Vertical; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Treatment Outcome | 2020 |
Developmental Consequences of Prenatal Telbivudine Exposure during the Third Trimester.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Prospective Studies; Telbivudine | 2021 |
Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study.
Topics: Adult; Female; Hepatitis B; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine | 2020 |
Efficacy and safety of telbivudine treatment for the prevention of HBV perinatal transmission.
Topics: Adult; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Treatment Outcome; Viral Load; Young Adult | 2020 |
Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up.
Topics: Antiviral Agents; Child Development; DNA, Viral; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Motor Skills; Nervous System; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Prospective Studies; Telbivudine; Treatment Outcome | 2021 |
Factors associated with non-compliance with breastfeeding recommendation: a retrospective survey in hepatitis B virus-infected mothers who had taken Nucleos(t)ide analogs during pregnancy.
Topics: Adult; Antiviral Agents; Breast Feeding; China; Female; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Nucleosides; Patient Compliance; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Risk Factors; Telbivudine; Tenofovir | 2021 |
Clinical and Immunological Factors Associated with Postpartum Hepatic Flares in Immune-Tolerant Pregnant Women with Hepatitis B Virus Infection Treated with Telbivudine.
Topics: Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunologic Factors; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Prospective Studies; Telbivudine; Thymidine | 2021 |
Safety and efficacy of telbivudine for chronic hepatitis B during the entire pregnancy: Long-term follow-up.
Topics: Antiviral Agents; Child Development; Child, Preschool; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Male; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Time Factors; Treatment Outcome | 2017 |
Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
Topics: Adult; Antiviral Agents; Case-Control Studies; DNA, Viral; Female; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Patient Safety; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pregnancy Trimester, First; Retrospective Studies; Telbivudine; Thymidine; Treatment Outcome; Viral Load | 2018 |
Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
Topics: Adult; Antiviral Agents; China; Female; Health Knowledge, Attitudes, Practice; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Seroepidemiologic Studies; Telbivudine; Thymidine; Viral Load; Young Adult | 2018 |
Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy.
Topics: Adolescent; Adult; Antiviral Agents; Case-Control Studies; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Telbivudine; Tenofovir; Viral Load; Young Adult | 2019 |
Ending vertical transmission of hepatitis B: the third trimester intervention.
Topics: Female; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine | 2014 |
Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Perinatal Care; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Treatment Outcome; Viral Load; Young Adult | 2014 |
Reduction of infectivity in chronic hepatitis B virus carriers among healthcare providers and pregnant women by antiviral therapy.
Topics: Adenine; Antiviral Agents; DNA, Viral; Female; Guanine; Health Personnel; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Professional-to-Patient; Infectious Disease Transmission, Vertical; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Viral Load; Viremia | 2014 |
Growth and development of children prenatally exposed to telbivudine administered for the treatment of chronic hepatitis B in their mothers.
Topics: Adult; Ankyloglossia; Antiviral Agents; Body Mass Index; Body Weight; Child Development; China; Delivery, Obstetric; Female; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Infant; Infectious Disease Transmission, Vertical; Male; Maternal-Fetal Exchange; Mouth Abnormalities; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Reference Values; Telbivudine; Thymidine | 2015 |
Tenofovir rescue therapy in pregnant females with chronic hepatitis B.
Topics: Adenine; Adult; Antiviral Agents; Apgar Score; Biomarkers; Birth Weight; China; DNA, Viral; Drug Resistance, Viral; Drug Substitution; Female; Genotype; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Live Birth; Male; Middle Aged; Mutation; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Vaccination; Viral Load; Young Adult | 2015 |
[Clinical observation of telbivudine's antiviral efficacy and protection against mother-to-infant transmission of chronic hepatitis B during the first trimester of pregnancy].
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis A Vaccines; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Mother-Child Relations; Mutation; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Telbivudine; Thymidine; Vaccines, Combined | 2015 |
[Predictive value of telbivudine in preventing mother-to-infant transmission of hepatitis B virus in pregnant women with high viremia].
Topics: Female; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Viremia | 2015 |
[Prevention of mother to child transmission of hepatitis B].
Topics: Adult; Antiviral Agents; Female; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine; Tenofovir; Thymidine; Viral Load; Young Adult | 2015 |
[The safety of telbivudine in preventing mother-to-infant transmission of hepatitis B virus in pregnant women after discontinuation].
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Mothers; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Young Adult | 2015 |
[Efficacy of combination antiviral therapy following childbirth in pregnant HBV carriers receiving telbivudine for prevention of mother-to-child transmission].
Topics: Adenine; Alanine Transaminase; Antiviral Agents; Carrier State; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Interferon-alpha; Organophosphonates; Polyethylene Glycols; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Recombinant Proteins; Telbivudine; Thymidine | 2015 |
Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Young Adult | 2017 |
[Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Telbivudine; Thymidine; Treatment Outcome; Viremia | 2016 |
Telbivudine treatment of hepatitis B virus-infected pregnant women at different gestational stages for the prevention of mother-to-child transmission: Outcomes of telbivudine treatment during pregnancy.
Topics: Adult; Antiviral Agents; Cohort Studies; Drug Administration Schedule; Female; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Pregnancy Trimester, Second; Telbivudine; Thymidine; Treatment Outcome; Young Adult | 2016 |
Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy.
Topics: Adult; Antiviral Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Telbivudine; Thymidine; Treatment Outcome; Young Adult | 2017 |
HBV treatment and pregnancy.
Topics: Female; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Male; Nucleosides; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Thymidine | 2011 |
Interruption of mother-to-infant transmission of hepatitis B: time to include selective antiviral prophylaxis?
Topics: Antiviral Agents; Developing Countries; Female; Hepatitis B; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nucleosides; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Vaccination | 2012 |
The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
Topics: Adenine; Antiviral Agents; Drug Approval; Drug Resistance, Viral; Female; Guanine; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Milk, Human; Netherlands; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Renal Insufficiency; Telbivudine; Tenofovir; Thymidine | 2012 |